Health Canada — Medical Devices · Canada · 2014-10-02 · Type II
🏛Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Archived by the issuing authority — kept for reference
Reported risk: Alcon is voluntarily discontinuing the Cachet Phakic Lens based on data analysis from an ongoing 10-year study to evaluate the safety of the Cachet Phakic Lens in patients with myopia (near-sightedness) from -6.0 to -16.5 D vision correction. Patients with the Cachet Phakic Lens should continue with the ongoing monitoring and evaluation outlined in the current directions for use (DFU). In cases where an explant is warranted in accordance with the criteria set out in the attached DFU, Alcon will work with the treating ophthalmologist to ensure that the affected patients receive an explant without incurring out-of-pocket costs.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.